Yeon Sook Kim

Dr. Yeon Sook Kim

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2020 in New England Journal of Medicine
Verified
Journal Article
Closed access
SSSusan Swindells
Susan Swindells
JAJaime-Federico Andrade-Villanueva
Jaime-Federico Andrade-Villanueva
GRGary J. Richmond
Gary J. Richmond
GRGiuliano Rizzardini
Giuliano Rizzardini
ABAxel Baumgarten
Axel Baumgarten
WSWilliam R. Spreen
William R. Spreen
Simplified regimens for the treatment of human immunodeficiency virus type 1 (HIV-1) infection may increase patient satisfaction and facilitate adherence.

20 February 2011 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
JSJae-Hoon Song
Jae-Hoon Song
PHPo-Ren Hsueh
Po-Ren Hsueh
DCDoo Ryeon Chung
Doo Ryeon Chung
Kwan Soo KoKwan Soo Ko
Kwan Soo Ko
CKCheol-In Kang
Cheol-In Kang
TNTran Van Ngoc
Tran Van Ngoc
Methicillin-resistant Staphylococcus aureus (MRSA) is highly prevalent in hospitals in many Asian countries. Recent emergence of community-associated (CA) MRSA worldwide has added another serious concern to the epidemiology of S. aureus infections. To understand the changing epidemiology of S. aureus infections in Asian countries, we performed a prospective, multinational surveillance study with molecular typing analysis. We evaluated the prevalence of methicillin resistance in S. aureus isolates in CA and healthcare-associated (HA) infections, and performed molecular characterization and antimicrobial susceptibility tests of MRSA isolates. MRSA accounted for 25.5% of CA S. aureus infections and 67.4% of HA infections. Predominant clones of CA-MRSA isolates were ST59-MRSA-SCCmec type IV-spa type t437, ST30-MRSA-SCCmec type IV-spa type t019 and ST72-MRSA-SCCmec type IV-spa type t324. Previously established nosocomial MRSA strains including sequence type (ST) 239 and ST5 clones were found among CA-MRSA isolates from patients without any risk factors for HA-MRSA infection. CA-MRSA clones such as ST59, ST30 and ST72 were also isolated from patients with HA infections. Our findings confirmed that MRSA infections in the community have been increasing in Asian countries. Data also suggest that various MRSA clones have spread between the community and hospitals as well as between countries.

5 May 2016 in Scientific Reports
Verified
Journal Article
Open access
CMChan-Ki Min
Chan-Ki Min
SCShinhye Cheon
Shinhye Cheon
NHNa-Young Ha
Na-Young Ha
KSKyung Mok Sohn
Kyung Mok Sohn
YKYuri Kim
Yuri Kim
YKYeon-Sook Kim
Yeon-Sook Kim
Despite the ongoing spread of MERS, there is limited knowledge of the factors affecting its severity and outcomes. We analyzed clinical data and specimens from fourteen MERS patients treated in a hospital who collectively represent a wide spectrum of disease severity, ranging from mild febrile illness to fatal pneumonia, and classified the patients into four groups based on severity and mortality. Comparative and kinetic analyses revealed that high viral loads, weak antibody responses, and lymphopenia accompanying thrombocytopenia were associated with disease mortality, whereas persistent and gradual increases in lymphocyte responses might be required for effective immunity against MERS-CoV infection. Leukocytosis, primarily due to increased neutrophils and monocytes, was generally observed in more severe and fatal cases. The blood levels of cytokines such as IL-10, IL-15, TGF-β, and EGF were either positively or negatively correlated with disease mortality. Robust induction of various chemokines with differential kinetics was more prominent in patients that recovered from pneumonia than in patients with mild febrile illness or deceased patients. The correlation of the virological and immunological responses with disease severity and mortality, as well as their responses to current antiviral therapy, may have prognostic significance during the early phase of MERS.

1 June 2007 in Journal of Infection
Verified
Journal Article
Closed access
DCD.R. Chung
D.R. Chung
SLS.S. Lee
S.S. Lee
HLH.R. Lee
H.R. Lee
HKHong Bin Kim
Hong Bin Kim
HCH.J. Choi
H.J. Choi
CPC.K. Park
C.K. Park

1 January 2020 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
KSKyung Mok Sohn
Kyung Mok Sohn
SLSung-Gwon Lee
Sung-Gwon Lee
HKHyeon Ji Kim
Hyeon Ji Kim
SCShinhyea Cheon
Shinhyea Cheon
HJHyeongseok Jeong
Hyeongseok Jeong
EJEun-Kyeong Jo
Eun-Kyeong Jo
Sohn KM, et al. J Korean Med Sci. 2020 Aug;35(38):e343. https://doi.org/10.3346/jkms.2020.35.e343

29 December 2016 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
SCSeong Jin Choi
Seong Jin Choi
SPSang-Won Park
Sang-Won Park
IBIn-Gyu Bae
In-Gyu Bae
SKSung-Han Kim
Sung-Han Kim
SRSeong Yeol Ryu
Seong Yeol Ryu
FNFor Korea Sfts Clinical Network
For Korea Sfts Clinical Network
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease that was recently identified in China, South Korea and Japan. The objective of the study was to evaluate the epidemiologic and clinical characteristics of SFTS in South Korea. SFTS is a reportable disease in South Korea. We included all SFTS cases reported to the Korea Centers for Disease Control and Prevention (KCDC) from January 2013 to December 2015. Clinical information was gathered by reviewing medical records, and epidemiologic characteristics were analyzed using both KCDC surveillance data and patient medical records. Risk factors for mortality in patients with SFTS were assessed. A total of 172 SFTS cases were reported during the study period. SFTS occurred throughout the country, except in urban areas. Hilly areas in the eastern and southeastern regions and Jeju island (incidence, 1.26 cases /105 person-years) were the main endemic areas. The yearly incidence increased from 36 cases in 2013 to 81 cases in 2015. Most cases occurred from May to October. The overall case fatality ratio was 32.6%. The clinical progression was similar to the 3 phases reported in China: fever, multi-organ dysfunction, and convalescence. Confusion, elevated C-reactive protein, and prolonged activated partial thromboplastin times were associated with mortality in patients with SFTS. Two outbreaks of nosocomial SFTS transmission were observed. SFTS is an endemic disease in South Korea, with a nationwide distribution and a high case-fatality ratio. Confusion, elevated levels of C-reactive protein, and prolonged activated partial thromboplastin times were associated with mortality in patients with SFTS. Severe fever with thrombocytopenia (SFTS) is an emerging infectious disease that was first discovered in China in 2009. Subsequently, SFTS has also been found in South Korea and Japan. Here, we report the epidemiologic and clinical characteristics of 172 confirmed SFTS cases in South Korea that occurred since the first case was reported in 2013. SFTS was prevalent throughout South Korea, except for in urban areas. The incidence was relatively low in the western and southwestern rice field areas and the scarcely populated eastern mountainous area. Hilly areas were the major endemic regions. The incidence was increasing annually, and the case fatality ratio was 32.6%. A mental status of confusion, elevated levels of C-reactive protein, and prolongation of activated partial thromboplastin time were associated with mortality in patients with SFTS. Two outbreaks of nosocomial SFTS transmission were noted.